News

Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders

by

TOKYO and SAN DIEGO, June 14, 2023 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) and Cullgen Inc. (President and CEO: Ying Luo, Ph.D., “Cullgen”) today announced a research collaboration and exclusive option agreement to discover multiple innovative protein degraders. Under the terms of the agreement, the two companies aim to develop multiple … Read more

Nippon Express Europe Exhibits at LogiPharma 2023 for First Time

by

TOKYO, June 15, 2023 /PRNewswire/ — Nippon Express Europe GmbH, a group company of NIPPON EXPRESS HOLDINGS, INC., exhibited for the first time at “LogiPharma 2023” held in Lyon, France, from Tuesday, April 25, to Thursday, April 27. Logo: https://kyodonewsprwire.jp/img/202306136298-O1-VPF88v28 Photo: https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202306136298/_prw_PI2fl_NJKJYRjE.jpg?_ga=2.3372912.1997240702.1686531031-1438572707.1685531252 LogiPharma 2023 is one of the world’s largest international pharmaceutical trade shows, focusing … Read more

Nippon Express Europe Exhibits at LogiPharma 2023 for First Time

by

TOKYO, June 15, 2023 /PRNewswire/ — Nippon Express Europe GmbH, a group company of NIPPON EXPRESS HOLDINGS, INC., exhibited for the first time at “LogiPharma 2023” held in Lyon, France, from Tuesday, April 25, to Thursday, April 27. Logo: https://kyodonewsprwire.jp/img/202306136298-O1-VPF88v28 Photo: https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202306136298/_prw_PI2fl_NJKJYRjE.jpg?_ga=2.3372912.1997240702.1686531031-1438572707.1685531252 LogiPharma 2023 is one of the world’s largest international pharmaceutical trade shows, focusing … Read more

Hamilton Offers In-Depth Exploration of DSP Operation Units and CPPs with New White Paper

by

BONADUZ, Switzerland, June 15, 2023 /PRNewswire/ — Hamilton has just released a comprehensive new white paper, “Biopharma PAT: Downstream Critical Process Parameters.” This whitepaper serves as a powerful resource for biopharma manufacturers seeking to design efficient and robust DSP processes and ensure product quality, safety, and efficacy in biopharmaceutical production. The document is compelling for … Read more

Medical cannabis company Better is suing InterCure

by

Better claims that InterCure, with which it was to merge, damaged Better’s assets and thwarted the merger deal. Better is seeking to compel InterCure to complete the merger and/or to pay a compensation of up to $35 million. TEL AVIV, Israel , June 14, 2023 /PRNewswire/ — Medical cannabis company Better is suing InterCure for $35 million. A lawsuit … Read more

111, Inc. Announces First Quarter 2023 Unaudited Financial Results

by

SHANGHAI, June 15, 2023 /PRNewswire/ — 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the first quarter ended March 31, 2023. First Quarter 2023 Highlights Net revenues were RMB3.7 billion (US$538.3 … Read more

Metagen Therapeutics Completes Series A Financing Raising a Total of 1.7 Billion Yen

by

TSURUOKA, Japan, June 15, 2023 /PRNewswire/ — Metagen Therapeutics (President & CEO: Taku Nakahara), a company focusing on drug discovery and development based on intestinal microbiome-based therapeutics for various diseases, has completed its Series A funding in 2 rounds, raising a total of 1.7 billion yen. Sparx Asset Management, Nippon Venture Capital, Mizuho Capital and … Read more

A1 Group, Inc. – Independent Directors and OTCQB Listing Update

by

SCOTTSDALE, Ariz., June 14, 2023 /PRNewswire/ — A1 Group, Inc. (the “Company” or “AWON”) would like to announce that as named two independent directors as part of its efforts to up list to OTCQB. The OTCQB, also called “The Venture Market,” is the middle tier of the over-the-counter (OTC) market for U.S. stocks. It was created in … Read more

EW Group Signs with China’s Largest Healthcare, Sinopharm

by

PETALING JAYA, Malaysia, June 15, 2023 /PRNewswire/ — European Wellness Biomedical Group (EW Group), announced its partnership with HK VJM Ltd (representing Sinopharm Cloud Health Technology (Guandong) Co. and Sinopharm Traditional Chinese Medicine (Foshan) Co.) and NCL Solutions Sdn Bhd on April 15, 2023 at One World Hotel. EW Group represented by Chairman, Prof. Dato’ Sri … Read more

GC Genome’s New Study Reveals Link Between Gut Microbiome and High Blood Pressure

by

– A large Korean population study provides scientific evidence that altering the gut microbiome composition through dietary habit change can help prevent and manage the hypertension YONGIN, South Korea, June 14, 2023 /PRNewswire/ — GC Genome Corporation, a leading genomic diagnostics company, announced the publication of a study in Frontiers in Microbiomes. This study demonstrates the … Read more